Novo Nordisk Says Fed Drug Pricing Unseen Even In Wartime

By Kaitlin Gebby · December 11, 2023, 6:37 PM EST

Novo Nordisk Inc. urged a New Jersey federal judge to grant it a win in its challenge to the Medicare drug price negotiation program, taking on both the Inflation Reduction Act's...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

NOVO NORDISK INC. et al v. BECERRA et al

Case Number

3:23-cv-20814

Court

New Jersey

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

September 29, 2023

Recent Articles By Kaitlin

February 14, 2024
Colo. Hospital Sued For Denying Gender Dysphoria Surgery
February 14, 2024
Mo. Hospital Faces Action Over Breach Of 500K Patients' Data
February 13, 2024
CMS Must Rethink $4M Training Contract Award, GAO Rules
February 12, 2024
GAO Says Ambiguity Protest Too Late In HHS Comms Deal
February 09, 2024
Healthcare Cybersecurity Bill Puts Focus On HHS Oversight
February 08, 2024
Conn. Doc Says Website Must Unmask Fake Online Reviewer
February 08, 2024
Exelixis GC Joins Board Of Biocom California Organization
February 05, 2024
Calif. Hospital To Pay $2.1M After Prescription Overbilling
February 02, 2024
Ascension Says Medical Queries Don't Breach Genetic Privacy
February 01, 2024
Drug Cos. Not Ready for 'Deep End' of Remote Trials